Daewon Pharmaceutical Co Ltd
KRX:003220
Dividends
Dividend Yield
Daewon Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Daewon Pharmaceutical Co Ltd
Daewon Pharmaceutical Co Ltd have
increased
by 157%.
Payout Ratio
Daewon Pharmaceutical Co Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Daewon Pharmaceutical Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
Price
Daewon Pharmaceutical Co Ltd
| Average Annual Return | -2.63% |
| Standard Deviation of Annual Returns | 11.88% |
| Max Drawdown | -52% |
| Market Capitalization | 245B KRW |
| Shares Outstanding | 22 430 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Daewon Pharmaceutical Co Ltd's latest stock split occurred on Mar 7, 2022
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Daewon Pharmaceutical Co Ltd traded at 19399.9997 per share. Afterward, the share price was about 18999.5665.
The adjusted shares began trading on Mar 7, 2022. This was Daewon Pharmaceutical Co Ltd's 17th stock split, following the previous one in Feb 18, 2021.
